BUZZ--美国股票走势-诺和诺德、TechTarget、Unicycive Therapeutics

路透中文

06/10

BUZZ--美国股票走势-<a href="https://laohu8.com/S/NVO">诺和诺德</a>、<a href="https://laohu8.com/S/TTGT">TechTarget</a>、Unicycive <a href="https://laohu8.com/S/LENZ">Therapeutics</a>

个股走势的 Eikon 搜索字符串：STXBZ

The Day Ahead时事通讯：https://refini.tv/3LI4BU7

新闻早报》通讯：https://refini.tv/3dKUyB8

6月10日 - 美国股指期货周二涨跌不一，投资者在等待美国和中国之间正在进行的贸易谈判的结果 (link)，谈判旨在为今年以来令全球市场遭受重创的关税争端降温。 .N

** Novo Nordisk A/S < NVO.N (link) >:BUZZ - 在有关Parvus建筑股份的报告发布后，股价上涨。 nL8N3SD0CF

** TechTarget Inc < TTGT.O (link) >:BUZZ - JP 摩根大通下调评级后股价下跌 nL4N3SD0JU

** Unicycive Therapeutics Inc < UNCY.O (link) >:BUZZ - 因 FDA 指出肾病药物存在生产问题而暴跌 nL4N3SD0NU

** Recursion Pharmaceuticals Inc < RXRX.O (link) >:BUZZ - 在裁员 20% 后上涨 nL4N3SD0OS

** J.M. Smucker Co < SJM.N (link) >:BUZZ - 在下调年度盈利预测后下跌 nL6N3SD0II

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2542468319"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542468319\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2542468319?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-06-10 19:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542468319","market":"us","top_or_hot":-1,"title":"BUZZ--美国股票走势-诺和诺德、TechTarget、Unicycive Therapeutics","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ--美国股票走势-<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>、<a href=\"https://laohu8.com/S/TTGT\">TechTarget</a>、Unicycive <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a></title></head><body><div><p>个股走势的 Eikon 搜索字符串：<span>STXBZ</span></p><p>The Day Ahead时事通讯：https://refini.tv/3LI4BU7</p><p>新闻早报》通讯：https://refini.tv/3dKUyB8</p></div><p><span>6月10日</span><span> - </span>美国股指期货周二涨跌不一，投资者在等待美国和中国之间正在进行的贸易谈判的结果 (link)，谈判旨在为今年以来令全球市场遭受重创的关税争端降温。 <span>.N</span></p><p>** Novo Nordisk A/S &lt; NVO.N (link) &gt;:BUZZ - 在有关Parvus建筑股份的报告发布后，股价上涨。   <span>nL8N3SD0CF</span> </p><p>** TechTarget Inc &lt; TTGT.O (link) &gt;:BUZZ - JP <a href=\"https://laohu8.com/S/JPM\">摩根大通</a>下调评级后股价下跌   <span>nL4N3SD0JU</span> </p><p>** Unicycive Therapeutics Inc &lt; UNCY.O (link) &gt;:BUZZ - 因 FDA 指出肾病药物存在生产问题而暴跌   <span>nL4N3SD0NU</span> </p><p>** Recursion Pharmaceuticals Inc &lt; RXRX.O (link) &gt;:BUZZ - 在裁员 20% 后上涨  <span>nL4N3SD0OS</span> </p><p>** J.M. Smucker Co &lt; SJM.N (link) &gt;:BUZZ - 在下调年度盈利预测后下跌   <span>nL6N3SD0II</span> </p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ--美国股票走势-诺和诺德、TechTarget、Unicycive Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ--美国股票走势-诺和诺德、TechTarget、Unicycive Therapeutics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-06-10 19:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ--美国股票走势-<a href=\"https://laohu8.com/S/NVO\">诺和诺德</a>、<a href=\"https://laohu8.com/S/TTGT\">TechTarget</a>、Unicycive <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a></title></head><body><div><p>个股走势的 Eikon 搜索字符串：<span>STXBZ</span></p><p>The Day Ahead时事通讯：https://refini.tv/3LI4BU7</p><p>新闻早报》通讯：https://refini.tv/3dKUyB8</p></div><p><span>6月10日</span><span> - </span>美国股指期货周二涨跌不一，投资者在等待美国和中国之间正在进行的贸易谈判的结果 (link)，谈判旨在为今年以来令全球市场遭受重创的关税争端降温。 <span>.N</span></p><p>** Novo Nordisk A/S &lt; NVO.N (link) &gt;:BUZZ - 在有关Parvus建筑股份的报告发布后，股价上涨。   <span>nL8N3SD0CF</span> </p><p>** TechTarget Inc &lt; TTGT.O (link) &gt;:BUZZ - JP <a href=\"https://laohu8.com/S/JPM\">摩根大通</a>下调评级后股价下跌   <span>nL4N3SD0JU</span> </p><p>** Unicycive Therapeutics Inc &lt; UNCY.O (link) &gt;:BUZZ - 因 FDA 指出肾病药物存在生产问题而暴跌   <span>nL4N3SD0NU</span> </p><p>** Recursion Pharmaceuticals Inc &lt; RXRX.O (link) &gt;:BUZZ - 在裁员 20% 后上涨  <span>nL4N3SD0OS</span> </p><p>** J.M. Smucker Co &lt; SJM.N (link) &gt;:BUZZ - 在下调年度盈利预测后下跌   <span>nL6N3SD0II</span> </p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0310799852.SGD","symbol_name":"FTIF - Templeton Global Equity Income A MDIS SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nL4S3SD0RU:1","article_id":"2542468319","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542468319","pubTimestamp":1749555539,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":".N** Novo Nordisk A/S < NVO.N  >:BUZZ - 在有关Parvus建筑股份的报告发布后，股价上涨。nL8N3SD0CF ** TechTarget Inc < TTGT.O  >:BUZZ - JP 摩根大通下调评级后股价下跌   nL4N3SD0JU ** Unicycive Therapeutics Inc < UNCY.O  >:BUZZ - 因 FDA 指出肾病药物存在生产问题而暴跌   nL4N3SD0NU ** Recursion Pharmaceuticals Inc < RXRX.O  >:BUZZ - 在裁员 20% 后上涨  nL4N3SD0OS ** J.M. Smucker Co < SJM.N  >:BUZZ - 在下调年度盈利预测后下跌   nL6N3SD0II (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","INF.UK":"英富曼集团","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0149725797.USD":"汇丰美国股市经济规模基金","IE00BHPRN162.USD":"BNY MELLON BLOCKCHAIN INNOVATION \"B\" (USD) ACC","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","BK4139":"生物科技","BK4611":"AI医疗","UNCY":"Unicycive Therapeutics, Inc.","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","BK4022":"陆运","BK4566":"资本集团","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU1629891620.HKD":"ALLIANZ INCOME AND GROWTH \"AMG2\" (H2-HKD) INC","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","TTGT":"TechTarget","ARCB":"ArcBest Corporation","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","BK4504":"桥水持仓","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","SJM":"斯马克","BK4232":"货物陆运","IE00BJTD4V19.USD":"NEUBERGER BERMAN US LONG SHORT EQUITY \"A1\" (USD) ACC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2360107168.USD":"BGF NEXT GENERATION TECHNOLOGY \"A4\" (USD) INC","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","LU2054465674.USD":"UBS (LUX) KEY SELEC SICAV DIGITAL TRANSFORMATION T \"P\" (USD) ACC","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4539":"次新股","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC"},"translate_title":"BUZZ--US Stock Moves-Novo Nordisk, TechTarget, Unicycive Therapeutics","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARCB":0.9,"INF.UK":0.9,"SJM":0.9,"TTGT":0.9,"UNCY":0.9},"content_text":"BUZZ--美国股票走势-诺和诺德、TechTarget、Unicycive Therapeutics个股走势的 Eikon 搜索字符串：STXBZThe Day Ahead时事通讯：https://refini.tv/3LI4BU7新闻早报》通讯：https://refini.tv/3dKUyB86月10日 - 美国股指期货周二涨跌不一，投资者在等待美国和中国之间正在进行的贸易谈判的结果 (link)，谈判旨在为今年以来令全球市场遭受重创的关税争端降温。 .N** Novo Nordisk A/S < NVO.N (link) >:BUZZ - 在有关Parvus建筑股份的报告发布后，股价上涨。   nL8N3SD0CF ** TechTarget Inc < TTGT.O (link) >:BUZZ - JP 摩根大通下调评级后股价下跌   nL4N3SD0JU ** Unicycive Therapeutics Inc < UNCY.O (link) >:BUZZ - 因 FDA 指出肾病药物存在生产问题而暴跌   nL4N3SD0NU ** Recursion Pharmaceuticals Inc < RXRX.O (link) >:BUZZ - 在裁员 20% 后上涨  nL4N3SD0OS ** J.M. Smucker Co < SJM.N (link) >:BUZZ - 在下调年度盈利预测后下跌   nL6N3SD0II (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}